(Q38504588)

3 September 2017

Fluoxetine in the treatment of premenstrual syndrome. (English)

1 reference

3 September 2017

premenstrual syndrome

1 reference

1 reference

Ozeren S

1

1 reference

3 September 2017

Corakçi A

2

1 reference

3 September 2017

Yücesoy I

3

1 reference

3 September 2017

Mercan R

4

1 reference

3 September 2017

Erhan G

5

1 reference

3 September 2017

language of work or name

1 reference

1 June 1997

1 reference

European Journal of Obstetrics Gynecology and Reproductive Biology

3 September 2017

1 reference

3 September 2017

73

1 reference

3 September 2017

2

1 reference

3 September 2017

167-170

1 reference

Late luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2897%2902741-3

7 January 2021

The assessment of the symptoms of premenstrual syndrome and their response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2897%2902741-3

7 January 2021

Premenstrual tension syndrome: the development of research diagnostic criteria and new rating scales

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2897%2902741-3

7 January 2021

The timing of menstruation-related symptoms assessed by a daily symptom rating scale

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2897%2902741-3

7 January 2021

Depressive episodes in premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2897%2902741-3

7 January 2021

Perimenstrual symptoms: prevalence and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2897%2902741-3

7 January 2021

The role of serotonin in premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2897%2902741-3

7 January 2021

Female-specific mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2897%2902741-3

7 January 2021

Is 5HT1A receptor subsensitivity a trait marker for late luteal phase dysphoric disorder? A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2897%2902741-3

7 January 2021

Menstrual cycle phase-related changes in appetite in patients with premenstrual syndrome and in control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2897%2902741-3

7 January 2021

Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2897%2902741-3

7 January 2021

The relationship of menstrually related mood disorders to psychiatric disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2897%2902741-3

7 January 2021

Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2897%2902741-3

7 January 2021

Open trial of fluoxetine therapy for premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2897%2902741-3

7 January 2021

A clinician's guide to the premenstrual syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2897%2902741-3

7 January 2021

10.1016/S0301-2115(97)02741-3

Identifiers

DOI

1 reference

3 September 2017

1 reference